Joshua Dennerlein
Stock Analyst at B of A Securities
(2.25)
# 2,550
Out of 4,784 analysts
89
Total ratings
45.9%
Success rate
-4.38%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
WELL Welltower | Maintains: Buy | $221 → $242 | $153.42 | +57.74% | 7 | Feb 18, 2025 | |
SUI Sun Communities | Downgrades: Underperform | $147 → $114 | $130.25 | -12.48% | 2 | Nov 12, 2024 | |
FVR FrontView REIT | Initiates: Buy | $22 | $12.89 | +70.67% | 1 | Oct 28, 2024 | |
GTY Getty Realty | Upgrades: Buy | $31 → $34 | $30.64 | +10.97% | 3 | Oct 21, 2024 | |
AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $30.43 | +1.87% | 2 | Sep 24, 2024 | |
NHI National Health Investors | Initiates: Buy | $92 | $74.70 | +23.16% | 1 | Sep 24, 2024 | |
ESS Essex Property Trust | Downgrades: Neutral | $307 → $321 | $306.00 | +4.90% | 3 | Sep 24, 2024 | |
LINE Lineage | Initiates: Buy | $100 | $58.98 | +69.55% | 1 | Aug 19, 2024 | |
CPT Camden Property Trust | Upgrades: Buy | $111 → $147 | $122.30 | +20.20% | 4 | Aug 12, 2024 | |
MAA Mid-America Apartment Communities | Upgrades: Buy | $144 → $189 | $165.90 | +13.92% | 3 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $51.70 | -22.63% | 4 | May 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $20.19 | +23.82% | 2 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $38.08 | -18.59% | 11 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $68.76 | -22.92% | 9 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $8.61 | -30.31% | 1 | Nov 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $44.54 | -25.91% | 1 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $15.84 | -5.30% | 2 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $56.61 | -8.14% | 1 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $17.54 | - | 4 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $62.70 | -13.88% | 4 | Sep 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $6.04 | +32.45% | 9 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $12.47 | +116.52% | 1 | Jun 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $21.88 | +53.11% | 5 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $32.60 | - | 4 | Aug 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $76.63 | +1.79% | 2 | Jun 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $42.09 | +11.67% | 2 | Jan 20, 2022 |
Welltower
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $153.42
Upside: +57.74%
Sun Communities
Nov 12, 2024
Downgrades: Underperform
Price Target: $147 → $114
Current: $130.25
Upside: -12.48%
FrontView REIT
Oct 28, 2024
Initiates: Buy
Price Target: $22
Current: $12.89
Upside: +70.67%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $30.64
Upside: +10.97%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $30.43
Upside: +1.87%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $74.70
Upside: +23.16%
Essex Property Trust
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $306.00
Upside: +4.90%
Lineage
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $58.98
Upside: +69.55%
Camden Property Trust
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $122.30
Upside: +20.20%
Mid-America Apartment Communities
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $165.90
Upside: +13.92%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $51.70
Upside: -22.63%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $20.19
Upside: +23.82%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $38.08
Upside: -18.59%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $68.76
Upside: -22.92%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $8.61
Upside: -30.31%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $44.54
Upside: -25.91%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $15.84
Upside: -5.30%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $56.61
Upside: -8.14%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $17.54
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $62.70
Upside: -13.88%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $6.04
Upside: +32.45%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $12.47
Upside: +116.52%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $21.88
Upside: +53.11%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $32.60
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $76.63
Upside: +1.79%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $42.09
Upside: +11.67%